Introduction: Very limited information is available regarding patient-reported health-related quality of life (HRQoL) and hip function following treatment for chronic periprosthetic hip joint infection (PJI). Patient-reported outcome measures provide essential information to clinicians of the impact a treatment have on patient's lives. The purpose of this study was to examine patient reported HRQoL and hip function after a completed re-implantation in a 2-stage revision. Method: 82 patients were identified retrospectively in the National Patient Register. 57 patients were alive and asked to complete the questionnaires EuroQol-5D (EQ-5D) and Oxford Hip Score (OHS) in November 2014. Results were compared to normative population data for EQ-5Dindex. Patients re-infected after a completed 2-stage revision were compared with not re-infected. Results: 45 patients completed the questionnaires. Mean time since re-implantation was 8.2 years (95% CI [confidence interval], 7.7-0.87). The EQ-5D index mean for the 2-stage group was 0.71 (0.64; 0.77) whereas the general population mean is 0.85 (0.84-0.85), p = 0.0004. The 2-stage revision patients scored significantly lower on every EQ-5D dimension. The re-infected group mean EQ-5D index score was significantly lower compared to the not re-infected group, p = 0.003. The EQ-VAS mean score was 58.2 (57.3-68.3) and the mean OHS for the group was 29.2 (25.4-33.0).
Introduction
Despite improved surgical techniques, periprosthetic hip joint infection (PJI) occur in varying severity in more than 1% of primary total hip arthroplasty (THA). 1 2-stage revision is currently regarded by many as the gold standard treatment in chronic hip PJI. 2 Patients undergo an interim period with limited mobility and possible complications associated with the use of a spacer or resection arthroplasty, and the need for multiple surgeries. This may contribute to poor rehabilitation, which could influence the functional outcome of this treatment with an influence on patient -satisfaction.
Even though revision surgery is performed according to current standards and with a good clinical outcome (no Patient-reported quality of life and hip function after 2-stage revision of chronic periprosthetic hip joint infection: a cross-sectional study re-infections), detailed outcome assessment on how the patient actually perceives his or her status is often neglected in outcome assessments. 3, 4 Furthermore, the majority of reports on 2-stage revision in PJI are caseseries from highly dedicated and experienced tertiary institutions. 3 As such, a recent review concludes that studies on 2-stage revision and health-related quality of life (HRQoL) are scarce. 4 Patient-reported outcome measures give essential information to clinicians who aim to decide on the most optimal treatment strategy in an everyday clinical setting.
The purpose of this study was to examine patientreported HRQoL and hip function after a completed reimplantation in a 2-stage revision.
Method and population

Method
The study was performed as a cross-sectional study on patients identified in the National Patient Register as part of a previously published data extraction. 5, 6 Follow-up on patients with verified PJIs with a performed 2-stage re-implantation was performed via local medical chart review and the nationwide electronic patient records at a minimum of 5 years after removal of the infected index THA. 11 departments of orthopaedic surgery participated in the study and these performed approximately 33% of all primary hip joint replacements (7, 998 performed nationwide) and 37% of all revisions (1,304 performed nationwide) in 2008. 7 The individual treatment strategy was decided at the discretion of the treating orthopaedic surgeon in collaboration with the patient, 2-stage revision being the standard of care at the time of the study period. All surgeons were dedicated lower limb reconstructive surgeons with experience in PJI. The study definition of PJI 3 both infection and re-infection, was adapted from previously published PJI criteria. 2, 8 The study was approved by The Danish Health and Medicines Authority Population 82 patients were verified with a completed re-implantation following a 2-stage revision in the study period from January 2003 to December 2008. All patients were operated via a posterior approach. 46 (56%) patients had a spacer in the interim period. In the interim period 3 patients had spacer dislocation and 3 had peri-spacer femoral fractures.
Re-implantation was performed based on an individual evaluation of the surgeon, with no standard protocol used for timing of the re-implantation procedure. The median interim period was 14 weeks (interquartile range [IQR] 10-18). At re-implantation 64 (78%) patients received a cementless stem and 67 (82%) patients a cementless cup. 16 different femoral components and 16 different acetabular components were used in the population. There were no registered pelvic discontinuities in any of the patients. 18 (22%) of the 82 patients were registered as re-infected in the follow-up period. 16 (20%) of the 82 patients were registered with aseptic surgery to the revision hip in the follow-up period.
25 (30%) patients had died at the time of the distribution of the questionnaires. 57 patients thus received the questionnaires EuroQol-5D (EQ-5D) and Oxford Hip Score (OHS) by mail in November 2014. The mean time from re-implantation to distribution of questionnaires was 8.2 years (95% confidence interval [CI] 7.7-8.7).
The patients who did not respond were contacted by phone and asked to send in their questionnaire, or offered to answer the questionnaire by phone. 45 (79%) patients completed the questionnaires. Of the 45 patients that responded, 98% correctly answered the OHS and EQ-VAS, and 100% the EQ-5D index. The study flow chart is shown in Figure 1 . For demographic and clinical parameters see Table 1 .
The questionnaires
EQ-5D is a standardised, generic instrument for describing and assessing HRQoL. EQ-5D generates 2 overall values for quality of life, 1 from the patient's perspective the EQ visual analogue scale (VAS) ("Current State of Health") and 1 from a societal perspective, the EQ-5D Index. In the EQ-VAS the patients are asked to evaluate their current state of health on a scale from 0 (worst imaginable) to 100 (best imaginable). The EQ-5D Index is a health profile that can be transformed into a global health index with a weighted total value for HRQoL, which represents the patient's description of their own health and how this health state relates to the health state of the general population. The EQ-5D Index is calculated from 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression on 1 out of 3 levels of severity: no problems, some/moderate problems, or extreme problems. 9 The Danish tariff has a range from -0.624 (worst) to 1 (best), and the questionnaire has been validated in a Danish setting assessed from the Danish general population. 10, 11 OHS is a disease-specific questionnaire consisting of 12 questions, which assess pain and function of the hip in relation to different activities of daily life. Each question is answered on a 5-point ordinal scale from 0 to 4, and is then totalled in to a score between 0 (worst) and 48 (best). 12 The OHS was developed specifically to assess the outcomes of hip replacement surgery, but has also been tested in relation to revision hip surgery. 13 It has been shown to be consistent, valid, and sensitive to clinical change, and has been validated in a Danish setting on patients with THA. 14 
Data analysis
A normal distribution was evaluated by plotting the data. Parametric data are presented as means with 95% confidence intervals (95% CI), nonparametric data as median with interquartile range (IQR) and dichotomous data is presented as prevalence. To compare groups, chi 2 -test, Fischer's exact or Mann-Whitney rank sum test were used on categorical data and nonparametric data, student's t-test on parametric data.
OHS missing items were handled in accordance with the directions specified by Murray et al (12) If only 1 or 2 questions have been left unanswered, it is feasible to enter a mean value representing all of their other responses. If more than 2 questions are unanswered, the overall score should not be calculated. For EQ-5D there was no imputing of -missing values. 9 Since follow-up varied, the cohort was divided into 2-year intervals, and it was assessed whether the cohort scores could be assembled into a single estimate. This was done by Kruskal-Wallis test, which did not detect any significant differences in mean HRQoL between the different years, and the HRQoL-scores were combined into single score, which were used for further analysis.
The EQ-5D scores were compared with age-and gender matched normative population data. Normative data were estimated from this study's baseline gender and age groups combined with their reported HRQoL data for gender and age groups. 11 A comparison between patients re-infected and not reinfected and their HRQoL and OHS was evaluated using multiple regression analysis. In the analyses we adjusted for age, gender, body mass index (BMI) and the interim period. Our HRQoL data had few observations and slightly skewed distributions. Therefore, in addition to parametric analyses, nonparametric bootstrap analyses were performed. The estimate was refitted to confirm the estimate and confidence intervals. Results of these nonparametric analyses were similar to the results obtained by the conventional parametric analyses. Data analysis was performed using STATA version 13 (StataCorp LP, college stations). The significance level was set at p<0.05.
Results
Demographic
The 45 patients responding to the questionnaires differed in several baseline clinical parameters compared with the non-responders (Table 1) . Non-responders were older (p = 0.02), more frequent smokers (p = 0.008), differed in BMI (p = 0.005), had worse American Society of Anesthesiologists (ASA) score, (ASA III: 24% vs. 2%, p = 0.05), and had longer length of stay in hospital (p = 0.002).
There was no difference between responders and nonresponders regarding re-infection rates (24% versus 19%, p = 0.14).
EQ-5D
The mean EQ-5D Index for the 2-stage group was 0.71 (0.64-0.77) compared to the population mean of 0.85 (0.84-0.85) (p = 0.0004). Table 2 shows the different levels of problems on the 5 EQ-5D dimensions. The 2-stage group scored significantly lower on every dimension. As depicted in Table 3 , the re-infected group mean EQ-5D Index score was significantly lower compared to the notre-infected group (p = 0.003).
For EQ-VAS the mean score was 58.2 (57.3-68.3).
OHS
The mean OHS score was 29.2 (25.4-33.0). In Table 4 the distribution of responses on OHS is depicted. The questions concerning "Usual pain in the hip" and "Limping when walking" are the 2 items with the highest score in the worst category, 18% and 32% respectively. We found no significant difference comparing the reinfected group to the not-re-infected group (p = 0.08).
Discussion
In this study, we evaluated patient-reported HRQoL and hip function in 1 of the largest 2-stage revision cohorts to date. As only about 1% of THA patients suffer from a PJI, and it is a condition associated with a high mortality, 7 , 15 limited number of patients are available for evaluation of patient-reported outcomes. Hence, the number of studies that have reported HRQoL after PJI is low. 4 We found that patients who completed a 2-stage revision and were alive for a long-term follow-up scored significantly lower than the general population on the EQ-5D Index. Our results are consistent with the findings of a recent review on published HRQoL scores after revision for PJI in THA. This review found that patients who received a 2-stage revision scored 12-27% lower on different HRQoL questionnaires compared to the general population 4 Our study found an EQ-5D Index score 16% lower than the general population. Previous studies have found that patients operated with a primary THA return to normative populations values. [16] [17] [18] [19] Jansson et al 16 analysed 2,444 patients with surgery performed for a variety of orthopaedic disabilities. Patients with scores lower than our study population included patients with rheumatoid arthritis (EQ-5D Index score 0.64), malignant tumours (EQ-5D Index score 0.71), spinal disorders (-EQ-5D Index score 0.61) and diabetes (EQ-5D Index score 0.66). Patients with higher scores included THA (EQ-5D Index score 0.8), knee -arthroplasty (-EQ-5D Index score 0.73), trauma (EQ-5D Index score 0.73) and benign tumours (EQ-5D Index score 0.8).
When comparing patients in our population, we found a significant lower score on EQ-5D Index when re-infected. Cahill et al 20 found that 12% of patients with infections in their group rated their health state equivalent to or worse than death. Patients who had their infection resolved or controlled did better, but were significantly worse than those in the uncomplicated group. This support the results in this study, where patients with re-infection had a worse score than patients not re-infected after the 2-stage revision. The mean EQ-VAS score in this study was 58.2, with no detected difference between those re-infected and those without signs of re-infection. Ostendorf et al 17 found a mean EQ-VAS score for 114 patients with THA of 76. Zampelis et al 21 reported on 45 patients 2 years after revision THA following aseptic loosening and found an EQ-VAS score on 73. The low EQ-VAS score obtained in our study could thus be related to the fact that our population consisted of patients with PJI, although a clear casual relationship cannot be established due to the design of our study. Kalairajah et al 22 developed categories for the Oxford Hip Score based on the Harris Hip Score for patients receiving a THA. They found a score of more than 41 was excellent, 34 to 41 good, 27 to 33 fair and less than 27 poor. This study found excellent 5-year scores on 200 primary THA using the developed categories. The mean OHS score in our study was 29.2, which is therefore perceived only as a fair result. We also note the deleterious effect of re-infection with these patients reporting a poorer result in the OHS score (Table 3 ). Dawson et al 13 found that the OHS deteriorated progressively in line with number of previous revisions. In this study 33% of the patient's index procedure was a revision. This could be an additional explanation for the low scores in our study.
Patients receiving 2-stage revision obtain lower HRQoL than patients after THA or revision surgery due to other reasons than infection. This could be due to numerous factors. In a qualitative review patient's experience on 2-stage revision were evaluated and indicated that 2-stage revision had great impact on patients' well being. This was mostly due to the interim period, which meant long periods of immobility and related psychological distress. During recovery on-going anxiety was caused by uncertainty about future return of infection that might result in future major surgery. Patients experienced pain and complications, and this could persist long after treatment. 23 We also found that a large proportion of the patients reporting problems with moderate or severe pain in the hip, as well as limping all the time, a long time after surgery (Table 4) .
The low score for these patients suggest a need for optimising the treatment for these patients.
Study limitations
There are a number of limitations that influence the interpretation and conclusion of the present study. The analysis was carried out as a cross-sectional study, and it was on average 8 years ago patients were operated. Therefore it is not possible to say whether the relationships are causal. When considering the age of the patients, comorbidities are also an aggravating factor in interpretation of the results, which is also highlighted in other studies. 19 The study collects data from many different hospitals and reflects a variety of surgical techniques and implants. This may be argued to be a weakness in this study as they can be potential confounders. On the other hand it could also be a strength, as it is a true reflection of overall current practice.
The 2-stage group is retrospectively selected, meaning that patients who were too ill to undergo surgery, or died, were not included in the study. The non-responder group had more frequent smokers, had worse ASA score and stayed longer in the hospital. Our established 2-stage group therefore consists of highly selected patients, yet this only emphasises the poor values obtained in this patient group compared, for instance, to primary THA.
Another limitation in this study is that only 45 patients completed the questionnaires. This may not have represented the group as whole. In the light of how difficult it is to collect data on these patients, and compared to other studies, it is however a reasonable number of patients included.
Conclusion
In conclusion, our follow-up on patients who have undergone 2-stage revision after a PJI indicate a lower score on HRQoL than perceived in the general population. 2-stage revision is a strenuous affair and the patients only obtain a seemingly fair clinical result. Patients who are deemed reinfected after 2-stage revision have even lower HRQoL, as one would expect. This study indicates the need for further investigation in PJI patients to find ways to optimise the treatment not only clinically, but especially in the patient perception of the treatment, which can elevate the HRQoL and patient-reported hip function.
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